CNA Staff, Apr 16, 2020 / 10:57 am
Catholic Health Services of Long Island is taking part in two Mayo Clinic trials designed to develop treatments for the new coronavirus (COVID-19).
"Our clinical teams have spent several weeks caring for COVID-19 patients. It means a great deal to everyone to take part in these two cutting-edge research efforts," Jason Golbin, CHS Senior Vice President and Chief Quality Officer, said in an April 15 release.
The first of the trials involves treatments using convalescent plasma, taken from the blood of people who have had COVID-19 and recovered. That trial is taking place at all of CHS' six hospitals.
The plasma can be administered only to a consenting COVID-19 patient, or a patient whose family member offers consent, CHS says, and will be given to those patients judged by a physician to be at high risk of disease progression to severe or life-threatening.